Journal
FRONTIERS IN IMMUNOLOGY
Volume 14, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2023.1108289
Keywords
actin cytoskeleton; adherens junctions; colonoids; cytokines; enteroids; epithelial barrier; inflammatory bowel diseases; tight junctions
Categories
Ask authors/readers for more resources
Disruption of the intestinal epithelial barrier is a common feature in mucosal inflammation, which leads to an inflammatory response. Previous studies on the breakdown of the gut barrier have mainly utilized colon cancer cell lines, which do not fully represent normal human intestinal epithelial cells. The development of human intestinal organoids provides a more physiologically-relevant platform to study the regulation and dysfunction of the intestinal barrier. This review discusses the use of human intestinal organoids to understand gut barrier disruption during mucosal inflammation, comparing them to conventional cell lines and identifying unique research questions that can be addressed using organoid platforms.
Disruption of the intestinal epithelial barrier is a hallmark of mucosal inflammation. It increases exposure of the immune system to luminal microbes, triggering a perpetuating inflammatory response. For several decades, the inflammatory stimuli-induced breakdown of the human gut barrier was studied in vitro by using colon cancer derived epithelial cell lines. While providing a wealth of important data, these cell lines do not completely mimic the morphology and function of normal human intestinal epithelial cells (IEC) due to cancer-related chromosomal abnormalities and oncogenic mutations. The development of human intestinal organoids provided a physiologically-relevant experimental platform to study homeostatic regulation and disease-dependent dysfunctions of the intestinal epithelial barrier. There is need to align and integrate the emerging data obtained with intestinal organoids and classical studies that utilized colon cancer cell lines. This review discusses the utilization of human intestinal organoids to dissect the roles and mechanisms of gut barrier disruption during mucosal inflammation. We summarize available data generated with two major types of organoids derived from either intestinal crypts or induced pluripotent stem cells and compare them to the results of earlier studies with conventional cell lines. We identify research areas where the complementary use of colon cancer-derived cell lines and organoids advance our understanding of epithelial barrier dysfunctions in the inflamed gut and identify unique questions that could be addressed only by using the intestinal organoid platforms.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available